876 related articles for article (PubMed ID: 18716065)
21. CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis.
Xia XM; Wang FY; Xu WA; Wang ZK; Liu J; Lu YK; Jin XX; Lu H; Shen YZ
World J Gastroenterol; 2010 Jun; 16(23):2873-80. PubMed ID: 20556832
[TBL] [Abstract][Full Text] [Related]
22. Attenuation by dietary taurine of dextran sulfate sodium-induced colitis in mice and of THP-1-induced damage to intestinal Caco-2 cell monolayers.
Zhao Z; Satsu H; Fujisawa M; Hori M; Ishimoto Y; Totsuka M; Nambu A; Kakuta S; Ozaki H; Shimizu M
Amino Acids; 2008 Jun; 35(1):217-24. PubMed ID: 17619120
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
24. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
[TBL] [Abstract][Full Text] [Related]
25. In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice.
Sun X; Yamada H; Yoshihara K; Awaya A; Yoshikai Y
Int Immunopharmacol; 2007 Jul; 7(7):928-36. PubMed ID: 17499195
[TBL] [Abstract][Full Text] [Related]
26. A novel mTOR inhibitor is efficacious in a murine model of colitis.
Bhonde MR; Gupte RD; Dadarkar SD; Jadhav MG; Tannu AA; Bhatt P; Bhatia DR; Desai NK; Deore V; Yewalkar N; Vishwakarma RA; Sharma S; Kumar S; Dagia NM
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1237-45. PubMed ID: 18927209
[TBL] [Abstract][Full Text] [Related]
27. Dextran sulphate sodium-induced colitis is ameliorated in interleukin 4 deficient mice.
Stevceva L; Pavli P; Husband A; Ramsay A; Doe WF
Genes Immun; 2001 Oct; 2(6):309-16. PubMed ID: 11607786
[TBL] [Abstract][Full Text] [Related]
28. Mycobacterium bovis Bacillus Calmette-Guérin killed by extended freeze-drying reduces colitis in mice.
Lagranderie M; Kluge C; Kiefer-Biasizzo H; Abolhassani M; Nahori MA; Fitting C; Huerre M; Bandeira A; Bercovier H; Marchal G
Gastroenterology; 2011 Aug; 141(2):642-52, 652.e1-4. PubMed ID: 21683076
[TBL] [Abstract][Full Text] [Related]
29. Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Katada K; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Watabe J; Yoshida N; Okanoue T; Yoshikawa T
J Nutr Biochem; 2006 Jun; 17(6):402-9. PubMed ID: 16214331
[TBL] [Abstract][Full Text] [Related]
30. Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice.
Katada K; Yoshida N; Suzuki T; Okuda T; Mizushima K; Takagi T; Ichikawa H; Naito Y; Cepinskas G; Yoshikawa T
Inflamm Res; 2008 Feb; 57(2):84-91. PubMed ID: 18288458
[TBL] [Abstract][Full Text] [Related]
31. Frontline: interferon regulatory factor-1 as a protective gene in intestinal inflammation: role of TCR gamma delta T cells and interleukin-18-binding protein.
Siegmund B; Sennello JA; Lehr HA; Senaldi G; Dinarello CA; Fantuzzi G
Eur J Immunol; 2004 Sep; 34(9):2356-64. PubMed ID: 15307168
[TBL] [Abstract][Full Text] [Related]
32. The opioid antagonist naltrexone improves murine inflammatory bowel disease.
Matters GL; Harms JF; McGovern C; Fitzpatrick L; Parikh A; Nilo N; Smith JP
J Immunotoxicol; 2008 Apr; 5(2):179-87. PubMed ID: 18569389
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis.
Panés J; Aceituno M; Gil F; Miquel R; Piqué JM; Salas A; McLean P
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G739-48. PubMed ID: 17656448
[TBL] [Abstract][Full Text] [Related]
34. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.
Ito R; Kita M; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Iwakura Y; Okanoue T; Yoshikawa T; Kataoka K; Mazda O
Biochem Biophys Res Commun; 2008 Dec; 377(1):12-6. PubMed ID: 18796297
[TBL] [Abstract][Full Text] [Related]
35. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
36. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon.
Vowinkel T; Anthoni C; Wood KC; Stokes KY; Russell J; Gray L; Bharwani S; Senninger N; Alexander JS; Krieglstein CF; Grisham MB; Granger DN
Gastroenterology; 2007 Mar; 132(3):955-65. PubMed ID: 17324402
[TBL] [Abstract][Full Text] [Related]
37. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
[TBL] [Abstract][Full Text] [Related]
38. SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation.
Uza N; Nakase H; Yamamoto S; Yoshino T; Takeda Y; Ueno S; Inoue S; Mikami S; Matsuura M; Shimaoka T; Kume N; Minami M; Yonehara S; Ikeuchi H; Chiba T
Gut; 2011 Nov; 60(11):1494-505. PubMed ID: 21471570
[TBL] [Abstract][Full Text] [Related]
39. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.
Melgar S; Karlsson L; Rehnström E; Karlsson A; Utkovic H; Jansson L; Michaëlsson E
Int Immunopharmacol; 2008 Jun; 8(6):836-44. PubMed ID: 18442787
[TBL] [Abstract][Full Text] [Related]
40. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis.
Myers KJ; Murthy S; Flanigan A; Witchell DR; Butler M; Murray S; Siwkowski A; Goodfellow D; Madsen K; Baker B
J Pharmacol Exp Ther; 2003 Jan; 304(1):411-24. PubMed ID: 12490618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
